These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS. Smith D J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565 [TBL] [Abstract][Full Text] [Related]
8. Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together. Messori A; Fadda V; Maratea D; Trippoli S J Neurol Sci; 2014 Dec; 347(1-2):408-10. PubMed ID: 25455308 [No Abstract] [Full Text] [Related]
9. Wegener's granulomatosis. Combined therapy with low-dosage systemic corticosteroids, azathioprine and cyclophosphamide in three patients. Keczkes K Br J Dermatol; 1976 Apr; 94(4):391-9. PubMed ID: 1268053 [TBL] [Abstract][Full Text] [Related]
10. Corticosteroids in combination therapy for multiple sclerosis. Cohen JA Lancet Neurol; 2009 Jun; 8(6):502-3. PubMed ID: 19409855 [No Abstract] [Full Text] [Related]
11. Multiple sclerosis. Ford H; Nicholas R Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466 [No Abstract] [Full Text] [Related]
12. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis. Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390 [TBL] [Abstract][Full Text] [Related]
13. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. Patti F; Amato MP; Filippi M; Gallo P; Trojano M; Comi GC J Neurol Sci; 2004 Aug; 223(1):69-71. PubMed ID: 15261564 [TBL] [Abstract][Full Text] [Related]